Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

Apr 29, 2021

SELL
$20.28 - $28.15 $203,388 - $282,316
-10,029 Closed
0 $0
Q4 2020

Jan 28, 2021

SELL
$24.73 - $35.12 $18,522 - $26,304
-749 Reduced 6.95%
10,029 $256,000
Q3 2020

Oct 29, 2020

BUY
$23.35 - $35.94 $251,666 - $387,361
10,778 New
10,778 $303,000

Others Institutions Holding RNA

About Avidity Biosciences, Inc.


  • Ticker RNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 52,127,000
  • Market Cap $1.85B
  • Description
  • Avidity Biosciences, Inc., a biopharmaceutical company, engages in the development of oligonucleotide-based therapies. It develops antibody oligonucleotide conjugates (AOC) that are designed to treat a range of serious diseases. The company's lead product candidate AOC 1001 is used for the treatment of myotonic dystrophy type 1, a rare monogenic...
More about RNA
Track This Portfolio

Track Dupont Capital Management Corp Portfolio

Follow Dupont Capital Management Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dupont Capital Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on Dupont Capital Management Corp with notifications on news.